跳至主要内容
临床试验/NCT02158299
NCT02158299Unknown4 期

Contrast The Role of Microfibrillar Collagen Hemostat Flour(Avitene) And OK-432 (Sapylin)in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
3
试验地点
1
主要终点
postoperative drainage magnitude

研究概览

简要总结

After Axillary lymphadenectomy for breast cancer there are not few patients showed seroma formation and it can not be ignored.Investigators aimed to study two new methods of application of Microfibrillar Collagen Hemostat Flour and OK-432 to reduce seroma formation and to verify the efficacy and safety of these two applications.Try to prove them as beneficial supplements for axillary lymphadenectomy of breast cancer.

详细描述

A prospective,randomized analysis of breast-conserving surgery or mastectomy plus axillary lymphadenectomy for those patients with sentinel node positive using Microfibrillar Collagen Hemostat Flour 、 OK-432 or using nothing in equal probability.Up to 12 months,a total of 180 will be recruited in plan.During the operation and after the axillary lymphadenectomy,according the arms,Investigators put Microfibrillar Collagen Hemostat Flour(avitene)、 OK-432(Sapylin) or nothing into patients axillary wounds。And Investigators will the statistical significance of these three arms that the postoperative drainage magnitude and duration.Also the complications associated with axillary lymphadenectomy will be studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients volunteered for the study and signed informed consent;
  • Preoperative biopsy or intraoperative sentinel lymph node biopsy confirmed axillary lymph node metastasis and need axillary lymphadenectomy
  • No penicillin allergy
  • No blood system diseases
  • No rheumatic heart disease
  • No history or family history of asthma
  • No history of axillary surgery

排除标准

  • A history of severe hypertension
  • A history of diabetes
  • Undergoing anticoagulant therapy or anticoagulant therapy drug withdrawal less than a year
  • Can not accept telephone follow-up or can not go to the hospital for subsequent inspection treatment

研究组 & 干预措施

Avitene,Drainaging,reexamine

Experimental

干预措施: Avitene (Drug)

Avitene,Drainaging,reexamine

Experimental

干预措施: axillary drainage (Behavioral)

Avitene,Drainaging,reexamine

Experimental

干预措施: reexamine (Other)

Sapylin,Drainaging,reexamine

Experimental

干预措施: Sapylin (Drug)

Sapylin,Drainaging,reexamine

Experimental

干预措施: axillary drainage (Behavioral)

Sapylin,Drainaging,reexamine

Experimental

干预措施: reexamine (Other)

Drainaging,reexamine

Active Comparator

干预措施: axillary drainage (Behavioral)

Drainaging,reexamine

Active Comparator

干预措施: reexamine (Other)

结局指标

主要结局

postoperative drainage magnitude

时间窗: up to 1 year

次要结局

  • Duration of the drainage(up to 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jia Weijuan

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

研究点 (1)

Loading locations...

相似试验